Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

brain

UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

Havas Lynx

- PMLiVE

Teva backs UK’s dementia drive with $21m investment

Pharma company will support National Institute for Health Research

- PMLiVE

G8 sets 2025 target for effective dementia treatment

World leaders pledge more research funding

- PMLiVE

Dementia map reveals extent of under-diagnosis

Less than half of patients in England are diagnosed

- PMLiVE

FDA approves Alzheimer’s diagnostic drug

GE Healthcare's Vizamyl to compete with Lilly's Amyvid

healthcare data technology

Data technology and value-based pricing

The value of adding post-approval data collating, monitoring and analysis to any discussion on drug pricing systems

- PMLiVE

Alzheimer’s disease pipeline takes multiple hits

Following a number of recent failures of clinical compounds, researchers are shifting the focus from late-stage disease to early-stage or prophylactic therapies

- PMLiVE

VIDEO: The impact of new technology on healthcare

Mindy Daeschner, director of PSHealth, explains how technology needs to be part of any discussion on the value of treatment

- PMLiVE

Future imperfect: How breakthrough technology can support healthcare

Current economic strategies are fundamentally flawed and the age of plenty is coming to an end, according one self-professed futurist. Could breakthrough technologies save humankind from a sticky end?

Doctors move dementia assessment from paper to smartphone

Evidence-based ACEmobile app soon to be launched

- PMLiVE

Janssen teams up with the NHS for dementia challenge

£150,000 innovation prize aims to identify and reward novel approaches to care

- PMLiVE

David Cameron wants UK to become more ‘dementia friendly’

Prime minister takes part in first DH sponsored Dementia Friends session

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links